Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$37.88 - $43.77 $39,319 - $45,433
1,038 New
1,038 $44,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $35.2 Million - $40.8 Million
707,286 New
707,286 $36.1 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $11.7 Million - $14.7 Million
-183,724 Reduced 25.31%
542,076 $34.8 Million
Q1 2022

May 09, 2022

BUY
$76.85 - $89.45 $55.8 Million - $64.9 Million
725,800 New
725,800 $56.3 Million
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $16.1 Million - $18.2 Million
-217,901 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $17.5 Million - $19.2 Million
217,901 New
217,901 $17.5 Million
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $4.79 Million - $5.39 Million
-62,689 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $3.94 Million - $4.3 Million
-52,212 Reduced 45.44%
62,689 $5.03 Million
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $9 Million - $10.4 Million
114,901 New
114,901 $9.24 Million
Q3 2019

Nov 13, 2019

SELL
$81.4 - $89.78 $651,200 - $718,240
-8,000 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$73.44 - $82.41 $283,551 - $318,185
-3,861 Reduced 32.55%
8,000 $655,000
Q1 2019

May 15, 2019

BUY
$64.48 - $81.31 $277,779 - $350,283
4,308 Added 57.04%
11,861 $964,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $40,987 - $51,892
667 Added 9.69%
7,553 $497,000
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $419,239 - $460,979
5,929 Added 619.54%
6,886 $531,000
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $230,187 - $273,662
-3,629 Reduced 79.13%
957 $71,000
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $286,900 - $331,384
4,586 New
4,586 $298,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.